How Cheminformatics Is Used in Drug Discovery in 2025?

Introduction

Cheminformatics is becoming an indispensable tool in drug discovery as we enter 2025 due to the exponential growth of chemical and biological data and the increasing demand for efficient, cost-effective R&D pipelines. This blog will explore how cheminformatics plays a crucial role in streamlining and enhancing the drug discovery process. We shall focus on the key areas such as data preprocessing, managing chemical libraries, predicting properties and toxicity, enhancing virtual screening and molecular docking, optimizing AI generated molecules, and integrating diverse data types.

Preprocessing & Structuring Chemical Data for AI Models

The foundation of any successful AI-driven drug discovery project lies in the quality and structure of the chemical data used. In 2025, preprocessing and structuring chemical data for AI models have become more sophisticated, leveraging advanced algorithms and tools. Basically it includes the following steps:

Data collection and initial preprocessing

Data collection involves gathering chemical data from various sources, including databases, literature, and experimental results, encompassing molecular structures, properties, and reaction data. Once collected, the data undergoes initial preprocessing, where duplicates are removed, errors are corrected, and formats are standardized to ensure consistency. Tools like RDKit are commonly used to facilitate this cleaning process, making the data suitable for further analysis.

Molecular representation

After preprocessing, the next step is choosing an appropriate molecular representation for the AI model, such as SMILES, InChI, or molecular graphs, each offering unique advantages based on the model's requirements. Once selected, the collected data is converted into the chosen format using tools like RDKit or Open Babel, ensuring compatibility with the analytical framework.

Feature extraction and engineering

Once the molecular data is converted into the chosen representation, the next step is feature extraction, where relevant properties such as molecular descriptors, fingerprints, or other structural characteristics are derived for use as AI model inputs. This is followed by feature engineering, which involves transforming or creating new features to enhance model performance. Techniques like normalization, scaling, and generating interaction terms help optimize the data for accurate predictions.

Data structuring for AI models

After feature extraction and engineering, the data is organized into a structured format suitable for AI models. This may involve creating labeled datasets for supervised learning or structuring data appropriately for unsupervised learning tasks. If needed, data augmentation techniques can be applied to expand the dataset size or enhance diversity, improving the robustness and generalization of AI models.

Integration with AI models

With the data prepared, the next step is model selection, where an appropriate AI model is chosen based on the specific task—neural networks for property prediction, clustering algorithms for molecular similarity analysis, or other machine learning techniques suited to the problem. Once selected, the model is trained using the preprocessed and structured data, followed by validation techniques to assess performance and ensure generalizability.

Postprocessing and analysis

After training and validation, the model output is analyzed to interpret its predictions or classifications, identifying key molecular features influencing its decisions. Based on these insights, an iterative refinement process is conducted, adjusting preprocessing steps, feature engineering, or model architecture to enhance performance and accuracy.

Managing & Filtering Chemical Libraries

Cheminformatics involves computational methods to manage, analyze, and predict properties of chemical compounds, focusing on data representation, storage, and analysis. It is distinct from bioinformatics, which deals with biological data, while cheminformatics handles chemical structures and properties. In 2025, cheminformatics will play a pivotal role in managing and filtering chemical libraries (image below), enhancing drug discovery processes.

Fig. Pipeline to optimize chemical libraries

Database management

Efficient database management systems are essential for handling large chemical libraries. In 2025, cloud-based solutions and distributed databases are commonly used to store and manage vast amounts of chemical data, allowing for quick retrieval and analysis. Common databases are PubChem, DrugBank, ZINC15, etc.

Filtering and prioritization

Cheminformatics tools apply filters based on physicochemical properties, drug-likeness, and other criteria to narrow down the search space. This process significantly reduces the number of compounds that need to be tested experimentally, saving time and resources. For example, substructure queries designed to identify compounds likely to produce artifacts in biochemical or cellular assays have been developed over the last 25 years. Moreover, molecular filters pioneered by Sebastjan and coworkers are used to tailor molecular libraries in a target-focused manner.

Structure searching and similarity analysis

Structure searching and similarity analysis are fundamental in cheminformatics for managing chemical libraries. Tools like RDKit are widely used for these purposes, providing extensive support for descriptor calculations and molecular modeling. These tools enable researchers to identify similar compounds and explore chemical space efficiently.

Data analysis and visualization

Data analysis and visualization are key for understanding and managing chemical libraries. The ChemicalToolbox, a web server for cheminformatics analysis, provides an intuitive interface for common tools, including those for downloading, filtering, visualizing, and simulating small molecules and proteins. Such tools are essential for transforming raw chemical data into actionable insights.

Chemical space mapping

Chemical space mapping is used to visualize and explore the vast array of possible chemical compounds. This technique helps in understanding the diversity and coverage of chemical libraries, which is crucial for drug discovery. Tools like RDKit and the chemistry development kit are instrumental in this process, allowing for the calculation of molecular descriptors and the visualization of chemical space.

Development of virtual chemical libraries

The development of virtual chemical libraries has seen significant advancements in 2025. OpenEye's Generative Chemistry, for instance, offers flexible approaches for generating virtual libraries for lead optimization and other drug discovery uses. Additionally, the size of readily accessible virtual chemical libraries now exceeds 75 billion make-on-demand molecules, which can be synthesized and delivered within weeks, expanding the space of ligands for virtual screening. Researchers created a virtual library of over 800,000 compounds, called the vIMS library. This was achieved by generating new compounds based on existing scaffolds and R-groups. These new compounds were then filtered to ensure they were drug-like and could be synthesized.

Predicting Chemical Properties and Toxicity

As cheminformatics advances toward 2025, it plays a pivotal role in predicting chemical properties and toxicity. By integrating machine learning and computational toxicology techniques, researchers can efficiently assess compound safety while minimizing reliance on traditional animal testing. This approach not only improves predictive accuracy but also aligns with regulatory standards for ethical testing.

Property prediction

Cheminformatics models help predict key drug properties such as solubility, permeability, and bioavailability. For example, the HobPre model developed by Wei and colleagues (2022) that forecasts human oral bioavailability, ensuring drug performance.

Toxicity assessment

Early toxicity prediction is crucial in drug discovery to prevent costly failures. Methods like Quantitative Structure-Activity Relationship (QSAR) modeling and read-across (RA) leverage physicochemical properties to assess potential toxicity risks, enabling informed decision-making. Additionally, molecular docking and pharmacophore mapping provide mechanistic insights into toxicity, guiding experimental validation and improving drug safety evaluation.

By combining cheminformatics with advanced AI-driven techniques, researchers can enhance drug discovery pipelines, improving efficiency and reducing ethical concerns associated with conventional toxicity testing.

Enhancing Virtual Screening & Molecular Docking

Cheminformatics is poised to significantly enhance virtual screening and molecular docking by 2025 through the integration of advanced machine learning and deep learning techniques. These methodologies facilitate the exploration of ultra-large virtual libraries, improving the accuracy and efficiency of drug discovery processes. Key strategies include the development of novel molecular representations and hybrid scoring functions that leverage both cheminformatics and molecular mechanics.

Virtual screening

Virtual screening employs computational techniques to analyze large libraries of chemical compounds and identify those most likely to interact with a biological target. It consists of two main approaches: Ligand-Based Virtual Screening (LBVS), which uses known active molecules to find structurally similar compounds, enhanced by machine learning models trained on molecular fingerprints and descriptors, and Structure-Based Virtual Screening (SBVS), which relies on the 3D structure of the target protein, using docking algorithms to predict binding affinities and rank compounds. By incorporating cheminformatics tools, virtual screening enhances hit-to-lead efficiency, allowing researchers to prioritize the most promising candidates for experimental validation.

Molecular docking

Molecular docking simulates the interaction between a small molecule and a protein target to predict its binding mode, affinity, and stability. It can be categorized into rigid docking, which assumes fixed conformations for both the ligand and protein, making it computationally efficient but less flexible, and flexible docking, which allows conformational changes in the ligand, receptor, or both, leading to more realistic interaction predictions. Advanced cheminformatics algorithms enhance docking accuracy by integrating scoring functions, molecular dynamics simulations, and free energy calculations, improving the identification of drug candidates with high binding specificity and stability.

Optimizing AI-Generated Molecules

The integration of cheminformatics and artificial intelligence (AI) has revolutionized the field of molecular design and optimization. As we approach 2025, the synergy between these two disciplines is expected to play a pivotal role in accelerating the discovery of novel molecules. This section will explore how cheminformatics can be effectively utilized to optimize AI-generated molecules.

De novo drug design

AI can generate novel molecules through de novo design, but these molecules often need optimization to meet drug development criteria. Cheminformatics tools can analyze and modify these molecules to enhance their properties, such as solubility and bioavailability. Techniques like PASITHEA employ gradient-based optimization to refine molecular structures, ensuring they meet predefined criteria such as solubility, bioavailability, and binding affinity.

Iterative optimization

Iterative optimization involves repeatedly refining AI-generated molecules based on feedback from cheminformatics models. This process can lead to the development of more effective and safer drug candidates. For example, CIME4R is an open-source interactive web application designed to enhance human-AI collaboration in chemical reaction optimization by enabling comprehensive analysis of reaction parameter spaces and AI model predictions.

Chemical space exploration

In cheminformatics, chemical space exploration involves systematically navigating vast molecular landscapes to identify novel therapeutic compounds and enhance molecular diversity. For example, transformer architecture uses SMILES structures to exhaust local chemical space.

Integrating Diverse Biological & Chemical Data

Integrating diverse biological and chemical data through cheminformatics in 2025 involves leveraging advanced computational tools and methodologies to create cohesive, interoperable datasets that enhance research and development across various scientific domains.

Development of integrated data pipelines

In cheminformatics, integrated data pipelines are crucial for efficiently managing vast chemical and biological datasets by streamlining data flow from acquisition to actionable insights. These pipelines involve collecting data from various sources, processing and transforming it into analyzable formats, applying statistical and machine learning models for predictions, and visualizing results for informed decision-making. Several tools support this process, such as MolPipeline for scalable cheminformatics tasks, BioMedR for comprehensive molecular analysis, Pipeline Pilot for intuitive workflow execution, and KNIME for flexible data integration and machine learning.

Implementation of in silico analysis platforms

Computational methods like molecular docking, quantum chemistry, and molecular dynamics simulations combine chemical and biological data to predict drug-target interactions and enhance compound properties. Platforms such as CACTI use clustering analysis to integrate chemogenomic data, allowing researchers to discover patterns and connections within large datasets. This can aid in the identification of new chemical motifs and potential drug targets.

Utilization of heterogeneous graphs

Heterogeneous graphs, also known as heterogeneous information networks (HINs) are used in cheminformatics to integrate and analyze complex relationships between diverse biological and chemical entities. Unlike homogeneous graphs, HINs consist of multiple node types (e.g., molecules, proteins) and varied edge relationships (e.g., drug-target interactions). HINs are used to integrate multiple omics data types with chemical data, enabling comprehensive analysis of complex biological and chemical interactions.

Conclusion

The field of cheminformatics is rapidly evolving, with AI-driven techniques now used in every step of the drug discovery process. As a result, there is a growing demand for skilled professionals who can navigate these advanced technologies.

Embark on your future in cheminformatics today. Enroll for Neovarsity's cheminformatics certification course to acquire career-defining skills and engage in real-world projects. Become an integral part of the future of drug discovery.

Frequently Asked Questions (FAQs)